Communiqués

03/07 Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR
23/06 Dexcom Further Advances Vision of Glucose Biosensing for All BU
06/06 Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin BU
04/06 Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026 BU
02/06 Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience BU
26/05 Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users BU
19/05 DexCom : Operations and Innovation Committee PU
18/05 Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany BU
14/05 Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day BU
06/05 DexCom : Trade Association Report 2025 PU
05/05 Dexcom to Host Investor Day on May 14, 2026 BU
30/04 DexCom: Q1 Earnings Snapshot AQ
30/04 Dexcom Reports First Quarter 2026 Financial Results BU
29/04 Why Medtech Giants Are Quietly Paying Up for AI Diagnostics AQ
10/04 Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR
02/04 Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time BU
11/03 Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026 BU
26/02 Dexcom Appoints Rick Osterloh to Board of Directors BU
26/02 HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS PR
25/02 Dexcom Announces Upcoming Conference Presentation BU
12/02 DexCom: Q4 Earnings Snapshot AQ
12/02 Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results BU
09/02 Medical Devices: Court Of Appeal Clarifies Novelty Requirements And Claim Interpretation In Latest Abbott v Dexcom Judgment AQ
04/02 Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management BU
29/01 HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS PR
Aucun résultat pour cette recherche